Abstract
Introduction: The 5-alpha-reductase inhibitor finasteride is used for the treatment of androgenic alopecia, benign prostate hyperplasia and prostate cancer. Besides inhibiting the conversion of testosterone to the biologically more active 5α-dihydrotestosterone, it also inhibits the production of neurosteroids. Decreased neurosteroid levels are postulated to be involved in the pathophysiology of psychiatric disorders such as depression. As neurosteroids metabolized by 5-alpha-reductase influence neural plasticity, we investigated whether finasteride treatment alters adult hippocampal neurogenesis, implicated in the pathophysiology of depression.
Methods: Male C57BL/6N mice were treated subchronically (7 days) with finasteride or vehicle. Adult neurogenesis was assessed at two different time points after treatment (day 1; day 35) using immunohistochemistry.
Results: Finasteride treatment led to a significant decrease in brain 5α-dihydrotestosterone levels and induced a reversible reduction in the number of newborn cells and young neurons in the hippocampus. 35 days after the last finasteride injection, neurogenesis had returned to normal.
Discussion: These data indicate that inhibition of 5-alpha-reductase activity by finasteride treatment influences neuronal plasticity on a structural level. These changes might contribute to the pathophysiology of depressive episodes observed after finasteride treatment.
References
-
1
Agis-Balboa RC, Pinna G, Pibiri F. et al .
Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice.
Proc Natl Acad Sci USA.
2007;
104
18736-18741
-
2
Agis-Balboa RC, Pinna G, Zhubi A. et al .
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis.
Proc Natl Acad Sci USA.
2006;
103
14602-14607
-
3
Altomare G, Capella GL.
Depression circumstantially related to the administration of finasteride for androgenetic alopecia.
J Dermatol.
2002;
29
665-669
-
4
Bartsch G, Rittmaster RS, Klocker H.
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
World J Urol.
2002;
19
413-425
-
5
Brinton RD, Wang JM.
Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease.
Curr Alzheimer Res.
2006;
3
11-17
-
6
Charalampopoulos I, Alexaki VI, Tsatsanis C. et al .
Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging.
Ann N Y Acad Sci.
2006;
1088
139-152
-
7
Charalampopoulos I, Remboutsika E, Margioris AN. et al .
Neurosteroids as modulators of neurogenesis and neuronal survival.
Trends Endocrinol Metab.
2008;
19
300-307
-
8
Ciriza I, Carrero P, Frye CA. et al .
Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective.
J Neurobiol.
2006;
66
916-928
-
9
Couillard-Despres S, Winner B, Schaubeck S. et al .
Doublecortin expression levels in adult brain reflect neurogenesis.
Eur J Neurosci.
2005;
21
1-14
-
10
Djebaili M, Guo Q, Pettus EH. et al .
The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats.
J Neurotrauma.
2005;
22
106-118
-
11
Djebaili M, Hoffman SW, Stein DG.
Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex.
Neuroscience.
2004;
123
349-359
-
12
Duskova M, Hill M, Hanus M. et al .
Finasteride treatment and neuroactive steroid formation.
Prague Med Rep.
2009;
110
222-230
-
13
Eser D, Baghai TC, Schule C. et al .
Neuroactive steroids as endogenous modulators of anxiety.
Curr Pharm Des.
2008;
14
3525-3533
-
14
Eser D, Schule C, Baghai TC. et al .
Neuroactive steroids and affective disorders.
Pharmacol Biochem Behav.
2006;
84
656-666
-
15
Eser D, Schule C, Baghai TC. et al .
Neuroactive steroids in depression and anxiety disorders: clinical studies.
Neuroendocrinology.
2006;
84
244-254
-
16
Finn DA, Beadles-Bohling AS, Beckley EH. et al .
A new look at the 5alpha-reductase inhibitor finasteride.
CNS Drug Rev.
2006;
12
53-76
-
17
Frank C, Giammarioli AM, Pepponi R. et al .
Cholesterol perturbing agents inhibit NMDA-dependent calcium influx in rat hippocampal primary culture.
FEBS Lett.
2004;
566
25-29
-
18
Frank C, Rufini S, Tancredi V. et al .
Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus.
Exp Neurol.
2008;
212
407-414
-
19
Frye CA.
Neurosteroids’ effects and mechanisms for social, cognitive, emotional, and physical functions.
Psychoneuroendocrinology.
2009;
34
(S 01)
S143-S161
-
20
Frye CA, Walf AA, Rhodes ME. et al .
Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5 alpha-reductase.
Brain Res.
2004;
1004
116-124
-
21
Galea LA, Uban KA, Epp JR. et al .
Endocrine regulation of cognition and neuroplasticity: our pursuit to unveil the complex interaction between hormones, the brain, and behaviour.
Can J Exp Psychol.
2008;
62
247-260
-
22
Gass P, Riva MA.
CREB, neurogenesis and depression.
Bioessays.
2007;
29
957-961
-
23
Ge S, Goh EL, Sailor KA. et al .
GABA regulates synaptic integration of newly generated neurons in the adult brain.
Nature.
2006;
439
589-593
-
24
Ge S, Sailor KA, Ming GL. et al .
Synaptic integration and plasticity of new neurons in the adult hippocampus.
J Physiol.
2008;
586
3759-3765
-
25
Ge S, Yang CH, Hsu KS. et al .
A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain.
Neuron.
2007;
54
559-566
-
26
Griffin LD, Mellon SH.
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes.
Proc Natl Acad Sci USA.
1999;
96
13512-13517
-
27
Guo J, Chi S, Xu H. et al .
Effects of cholesterol levels on the excitability of rat hippocampal neurons.
Mol Membr Biol.
2008;
25
216-223
-
28
Janowsky JS.
Thinking with your gonads: testosterone and cognition.
Trends Cogn Sci.
2006;
10
77-82
-
29
Kempermann G.
The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for?.
Trends Neurosci.
2008;
31
163-169
-
30
Kempermann G, Gage FH.
Experience-dependent regulation of adult hippocampal neurogenesis: effects of long-term stimulation and stimulus withdrawal.
Hippocampus.
1999;
9
321-332
-
31
Kempermann G, Jessberger S, Steiner B. et al .
Milestones of neuronal development in the adult hippocampus.
Trends Neurosci.
2004;
27
447-452
-
32
Kokate TG, Banks MK, Magee T. et al .
Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.
J Pharmacol Exp Ther.
1999;
288
679-684
-
33
Kuhn HG, Dickinson-Anson H, Gage FH.
Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation.
J Neurosci.
1996;
16
2027-2033
-
34
Lambert JJ, Cooper MA, Simmons RD. et al .
Neurosteroids: Endogenous allosteric modulators of GABA(A) receptors.
Psychoneuroendocrinology.
2009;
34
(S 01)
S48-S58
-
35
Laplagne DA, Kamienkowski JE, Esposito MS. et al .
Similar GABAergic inputs in dentate granule cells born during embryonic and adult neurogenesis.
Eur J Neurosci.
2007;
25
2973-2981
-
36
Locchi F, Dall’olio R, Gandolfi O. et al .
Olanzapine counteracts stress-induced anxiety-like behavior in rats.
Neurosci Lett.
2008;
438
146-149
-
37
Marx CE, Stevens RD, Shampine LJ. et al .
Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics.
Neuropsychopharmacology.
2006;
31
1249-1263
-
38
Marx CE, Trost WT, Shampine LJ. et al .
The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease.
Biol Psychiatry.
2006;
60
1287-1294
-
39
Marx CE, VanDoren MJ, Duncan GE. et al .
Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents.
Neuropsychopharmacology.
2003;
28
1-13
-
40
Marx CE, Yuan P, Kilts JD. et al .
Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice.
Int J Neuropsychopharmacol.
2008;
11
547-552
-
41
Mellon SH.
Neurosteroid regulation of central nervous system development.
Pharmacol Ther.
2007;
116
107-124
-
42
Mirescu C, Gould E.
Stress and adult neurogenesis.
Hippocampus.
2006;
16
233-238
-
43
Moffat SD, Zonderman AB, Metter EJ. et al .
Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men.
J Clin Endocrinol Metab.
2002;
87
5001-5007
-
44
Molina-Hernandez M, Tellez-Alcantara NP, Olivera-Lopez JI. et al .
Olanzapine plus 17-beta estradiol produce antidepressant-like actions in rats forced to swim.
Pharmacol Biochem Behav.
2009;
93
491-497
-
45
Mukai Y, Higashi T, Nagura Y. et al .
Studies on neurosteroids XXV. Influence of a 5alpha-reductase inhibitor, finasteride, on rat brain neurosteroid levels and metabolism.
Biol Pharm Bull.
2008;
31
1646-1650
-
46
Pibiri F, Nelson M, Guidotti A. et al .
Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder.
Proc Natl Acad Sci USA.
2008;
105
5567-5572
-
47
Pinna G, Costa E, Guidotti A.
Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake.
Psychopharmacology (Berl).
2006;
186
362-372
-
48
Rahimi-Ardabili B, Pourandarjani R, Habibollahi P. et al .
Finasteride induced depression: a prospective study.
BMC Clin Pharmacol.
2006;
6
7
-
49
Romeo E, Strohle A, Spalletta G. et al .
Effects of antidepressant treatment on neuroactive steroids in major depression.
Am J Psychiatry.
1998;
155
910-913
-
50
Romer B, Lewicka S, Kopf D. et al .
Cortisol metabolism in depressed patients and healthy controls.
Neuroendocrinology.
2009;
90
301-306
-
51
Romer B, Sartorius A, Inta D. et al .
Imaging new neurons in vivo: a pioneering tool to study the cellular biology of depression?.
Bioessays.
2008;
30
806-810
-
52
Rubinow DR, Schmidt PJ.
Androgens, brain, and behavior.
Am J Psychiatry.
1996;
153
974-984
-
53
Schule C, Romeo E, Uzunov DP. et al .
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
Mol Psychiatry.
2006;
11
261-272
-
54
Singh S, Hota D, Prakash A. et al .
Allopregnanolone, the active metabolite of progesterone protects against neuronal damage in picrotoxin-induced seizure model in mice.
Pharmacol Biochem Behav.
2010;
94
416-422
-
55
Spritzer MD, Galea LA.
Testosterone and dihydrotestosterone, but not estradiol, enhance survival of new hippocampal neurons in adult male rats.
Dev Neurobiol.
2007;
67
1321-1333
-
56
Thompson IM, Goodman PJ, Tangen CM. et al .
The influence of finasteride on the development of prostate cancer.
N Engl J Med.
2003;
349
215-224
-
57
Uzunova V, Sheline Y, Davis JM. et al .
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.
Proc Natl Acad Sci USA.
1998;
95
3239-3244
-
58
Walf AA, Sumida K, Frye CA.
Inhibiting 5alpha-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats.
Psychopharmacology (Berl).
2006;
186
302-311
-
59
Wang JM, Johnston PB, Ball BG. et al .
The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression.
J Neurosci.
2005;
25
4706-4718
-
60
Wang JM, Irwin RW, Liu L. et al .
Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.
Curr Alzheimer Res.
2007;
4
510-517
-
61
Wang JM, Liu L, Irwin RW. et al .
Regenerative potential of allopregnanolone.
Brain Res Rev.
2008;
57
398-409
-
62
Zhao C, Deng W, Gage FH.
Mechanisms and functional implications of adult neurogenesis.
Cell.
2008;
132
645-660
Correspondence
B. RömerMD
Central Institute of
Mental Health
J5
68159 Mannheim
Germany
Phone: +49/621/17 030
Email: benedikt.roemer@zi-mannheim.de
